90 related articles for article (PubMed ID: 7515743)
1. Inhibition of human immunodeficiency virus proliferation by macrocyclic polyamines and their metal complexes.
Inouye Y; Kanamori T; Yoshida T; Bu X; Shionoya M; Koike T; Kimura E
Biol Pharm Bull; 1994 Feb; 17(2):243-50. PubMed ID: 7515743
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins.
Yusa K; Oh-hara T; Tsukahara S; Baba K; Taniguchi M; Kozawa M; Takeuchi S; Hara H; Tsuruo T
Antiviral Res; 1994 Sep; 25(1):57-66. PubMed ID: 7529015
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
4. Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes.
Ding L; Balzarini J; Schols D; Meunier B; de Clercq E
Biochem Pharmacol; 1992 Oct; 44(8):1675-9. PubMed ID: 1384504
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
6. Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication.
Baur A; Harrer T; Peukert M; Jahn G; Kalden JR; Fleckenstein B
Klin Wochenschr; 1991 Oct; 69(15):722-4. PubMed ID: 1724477
[TBL] [Abstract][Full Text] [Related]
7. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.
Nakashima H; Shoji Y; Kim SG; Shimada J; Mizushima Y; Ito M; Yamamoto N; Takaku H
Nucleic Acids Res; 1994 Nov; 22(23):5004-10. PubMed ID: 7528375
[TBL] [Abstract][Full Text] [Related]
8. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
[TBL] [Abstract][Full Text] [Related]
10. Novel assay system favorable for the study of cell-to-cell transmission of HIV-1 and its application to the evaluation of anti-HIV drugs.
Inouye Y; Kanamori T; Fujimoto Y; Sugiyama M; Yoshida T
Biol Pharm Bull; 1995 Jun; 18(6):920-2. PubMed ID: 7550135
[TBL] [Abstract][Full Text] [Related]
11. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
[TBL] [Abstract][Full Text] [Related]
12. Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV.
Witvrouw M; Pannecouque C; Van Laethem K; Desmyter J; De Clercq E; Vandamme AM
AIDS; 1999 Aug; 13(12):1477-83. PubMed ID: 10465070
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker.
Bridger GJ; Skerlj RT; Thornton D; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Yamamoto N; De Vreese K; Pauwels R
J Med Chem; 1995 Jan; 38(2):366-78. PubMed ID: 7830280
[TBL] [Abstract][Full Text] [Related]
14. S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
Daelemans D; Esté JA; Witvrouw M; Pannecouque C; Jonckheere H; Aquaro S; Perno CF; De Clercq E; Vandamme AM
Mol Pharmacol; 1997 Dec; 52(6):1157-63. PubMed ID: 9396786
[TBL] [Abstract][Full Text] [Related]
15. Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase.
Moore PS; Jones CJ; Mahmood N; Evans IG; Goff M; Cooper R; Hay AJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):129-34. PubMed ID: 7536411
[TBL] [Abstract][Full Text] [Related]
16. Effect of cacao husk extract on human immunodeficiency virus infection.
Unten S; Ushijima H; Shimizu H; Tsuchie H; Kitamura T; Moritome N; Sakagami H
Lett Appl Microbiol; 1991 Dec; 13(6):251-4. PubMed ID: 1367748
[TBL] [Abstract][Full Text] [Related]
17. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
[TBL] [Abstract][Full Text] [Related]
18. Unintegrated DNA in cells infected in vitro with human immunodeficiency virus (HIV): a new approach to suppression of virus release.
Masuda T; Harada S
J Virol Methods; 1990 Jun; 28(3):219-33. PubMed ID: 1696587
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin.
Momota K; Kaneko I; Kimura S; Mitamura K; Shimada K
Biochem Biophys Res Commun; 1991 Aug; 179(1):243-50. PubMed ID: 1715691
[TBL] [Abstract][Full Text] [Related]
20. 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.
Balzarini J; Pérez-Pérez MJ; San-Félix A; Schols D; Perno CF; Vandamme AM; Camarasa MJ; De Clercq E
Proc Natl Acad Sci U S A; 1992 May; 89(10):4392-6. PubMed ID: 1374900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
